380 related articles for article (PubMed ID: 11383756)
1. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
2. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
[TBL] [Abstract][Full Text] [Related]
3. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Evans EG; Sigurgeirsson B
BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine: a review of its use in onychomycosis in adults.
Darkes MJ; Scott LJ; Goa KL
Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials.
Bootman JL
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S69-72. PubMed ID: 9594941
[TBL] [Abstract][Full Text] [Related]
9. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
10. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
11. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Gupta AK
J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
Salo H; Pekurinen M
Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT
Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902
[TBL] [Abstract][Full Text] [Related]
16. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
17. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
18. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
[TBL] [Abstract][Full Text] [Related]
19. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
20. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
